Advertisement
Letter|Articles in Press, 155560

Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences

  • Shuai Yuan
    Affiliations
    Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
    Search for articles by this author
  • Susanna C. Larsson
    Correspondence
    Corresponding author at: Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
    Affiliations
    Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
    Search for articles by this author
Published:April 15, 2023DOI:https://doi.org/10.1016/j.metabol.2023.155560
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences
Previous ArticleLetter to the Editor: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences
Next ArticleEpidemiology of sarcopenia: Prevalence, risk factors, and consequences
      We thank Muralidhar and Madhivanan for paying attention to our paper and raising some insightful concerns. We have replied to these comments as below.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Carvalho do Nascimento P.R.
        • Bilodeau M.
        • Poitras S.
        How do we define and measure sarcopenia? A meta-analysis of observational studies.
        Age Ageing. 2021; 50: 1906-1913
        View in Article
        • Petermann-Rocha F.
        • Balntzi V.
        • Gray S.R.
        • Lara J.
        • Ho F.K.
        • Pell J.P.
        • et al.
        Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis.
        J Cachexia Sarcopenia Muscle. 2022; 13: 86-99
        View in Article
        • Yuan S.
        • Larsson S.C.
        Epidemiology of sarcopenia: prevalence, risk factors, and consequences.
        Metabolism. 2023; 155533
        View in Article

      Article info

      Publication history

      Published online: April 15, 2023
      Accepted: April 12, 2023
      Received: April 11, 2023

      Publication stage

      In Press Journal Pre-Proof

      Identification

      DOI: https://doi.org/10.1016/j.metabol.2023.155560

      Copyright

      © 2023 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX